Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity
Publication date: Available online 24 May 2020Source: The Journal of Steroid Biochemistry and Molecular BiologyAuthor(s): Armina Kazi, Olga Goloubeva, Amanda Schech, Stephen Yu, Gauri J Sabnis
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
More News: Biochemistry | Biology | Breast Cancer | Cancer | Cancer & Oncology | Hormones | Men | Menopause | Molecular Biology